Webinar Międzynarodowego Towarzystwa Lipidologicznego

Rejestracja: https://ilep.eu/registration/?fbclid=IwAR1V87P5sRjplWhiHGKEiRf55G7-RuZePq2sZG2H8qUSlGODQYi4umkr_Ng

– What are the best experiences on effective diagnosis of FH patients? Do we really need systemic solutions? 

– How optimally manage with severe hypercholesterolemia patients, including FH patients, in Covid-19 pandemic based on the new ILEP and FH Europe recommendations,

– New data on drugs with the possible applications in FH patients (recent PCSK9 studies, recent data on fixed combination of statins and ezetimibe, bempedoic acid),

– The status of reimbursement of PCSK9 inhibitors in Europe countries and whether pandemic might be used to extend the existing reimbursement programs; 

– FH patients at very high and extremely high risk – how to effectively achieve <55 and <40 mg/dl? 

Experts:

Prof. Maciej Banach Polish Mother’s Memorial Hospital – Research Institute, Lodz (Poland)	Prof. Michal Vrablik Charles University of Prague, Prague (Czechia)	Prof. Ivan Pećin University Hospital Centre Zagreb (Croatia)	Prof. Branislav Vohnout Slovak Medical University in Bratislava, Bratislava (Slovakia)